InvestorsHub Logo
Followers 2
Posts 17
Boards Moderated 0
Alias Born 04/09/2020

Re: suny0501 post# 87789

Friday, 06/26/2020 11:20:08 AM

Friday, June 26, 2020 11:20:08 AM

Post# of 232530
(Thoughts BlackOps and others?) The Atlanta Journal article a few days back referenced a study of using COVID on "survivors" to see potential benefit of LERON on resolving issues/improving the immune system after the fact (see below). That stuck with me! It surprised me as I hadn't heard of that, but if the article is accurate and Dr Reisman isn't just anecdotal, then this opens a whole new large market to add to Black Ops BIG PICTURE.

"Reisman knew about a post-COVID trial for survivors of mild to moderate COVID-19 symptoms. Riley enrolled in the clinical trial for leronlimab, a drug that was originally developed to treat HIV, but is showing promise in the coronavirus fight. He had four injections in his stomach over two weeks. Riley said he immediately felt better. He returned to a faster pace, his blood pressure returned to normal and the other symptoms – the anxiety, the insomnia — faded. It’s possible he was given a placebo or perhaps it was time that helped him heal, but Riley is confident that it was the leronlimab."


https://www.ajc.com/lifestyles/health/for-some-with-covid-symptoms-can-linger-for-weeks-even-months/0rzLkWZWeXh0D2y3ezEqcN/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News